Modelled DT Structure
Method: multi-sequence alignment based machine learning
Detail: Structure Info
Drug Transporter (DT) Information
| General Information of DT | |||||
|---|---|---|---|---|---|
| DT ID | DTD0341 | ||||
| Gene Name | SLC39A13 | ||||
| Protein Name | Zinc transporter ZIP13 | ||||
| Gene ID | |||||
| UniProt ID | |||||
| TCDB ID | |||||
| 3D Structure |
|
||||
| Synonyms | EDSSPD3; LIV-1 subfamily of ZIP zinc transporter 9; LZT-Hs9; SCDEDS; SLC39A13; Solute carrier family 39 member 13; ZIP-13; ZIP13; Zinc transporter ZIP13 | ||||
| DT Family | Zinc (Zn(2+))-Iron (Fe(2+)) Permease (ZIP) Family ; | ||||
| Function | This transporter scts as a zinc-influx transporter. | ||||
| Endogenous Substrate(s) | Zn2+ | ||||
| Variability Data of This Drug Transporter (DT) | |||||
|
Regulatory Variability Data of This DT (VARIDT 4.0) |
|||||
|
(α) Tissue Distribution Level of Zinc transporter ZIP13 |
|||||
|
(β) Cell Distribution Level of Zinc transporter ZIP13 |
|||||
|
(γ) Organelle Distribution Level of Zinc transporter ZIP13 |
|||||
|
Regulatory Variability Data of This DT |
|||||
|
(α) Microbiota Influence of Zinc transporter ZIP13 |
|||||
|
(β) Post-translational Modification of Zinc transporter ZIP13 |
|||||
|
(γ) Transcriptional Regulation of Zinc transporter ZIP13 |
|||||
|
(δ) Epigenetic Regulation of Zinc transporter ZIP13 |
|||||
|
(ε) Exogenous Modulation of Zinc transporter ZIP13 |
|||||
|
General Variability Data of This DT |
|||||
|
(α) Genetic Polymorphisms of Zinc transporter ZIP13 |
|||||
|
(β) Disease-specific Protein Abundances of Zinc transporter ZIP13 |
|||||
|
(γ) Species- and Tissue-specific DT Abundances |
|||||
| Molecular Transporting Profile of This DT | |||||
|
Full List of Drug(s) Transported by This DT |
|||||
|
Withdrawn, Discontinued or Preclinical Drug |
Click to Show/Hide the Full List of Drug: 1 Drugs in Total | ||||
| Drug Name | Highest Status | Detail | Indication | ICD 11 | Ref |
|
Zinc salts
|
Preclinical | Drug Info | Arthritis | FA5Z | [1] |
| References | |||||
| 1 | Promotion of vesicular zinc efflux by ZIP13 and its implications for spondylocheiro dysplastic Ehlers-Danlos syndrome. Proc Natl Acad Sci U S A. 2012 Dec 18;109(51):E3530-8. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.